Process for the selective modulation of the expression and...

Details Process for the selective modulation of the expression and... Process for the selective modulation of the expression and...

A - Human Necessities

61

K

A61K 31/70 (2006.01)

Patent

CA 2041884

ABSTRACT OF THE DISCLOSURE Use of N-dichloroacetyl lysoganyliosides, e.g. N- dichloroacetyl lyso GM1, in the manufacture or preparation of a pharmaceutical formulation for selectively modulating the CD4 determinant present on the surface of human cells. This modulation can be used therapeutically to treat neuroimmunopathological conditions or neuroimmunopathology associated with infection by viruses e.g. the HIV-I virus.

Affiliated with

Also associated with

Rating

Process for the selective modulation of the expression and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for the selective modulation of the expression and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the selective modulation of the expression and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1345748